A dual role of human tRNA methyltransferase hTrmt13 in regulating translation and transcription.
Hao LiHan DongBei-Si XuQing-Ping XiongCai-Tao LiWen-Qing YangJing LiZhi-Xuan HuangQi-Yu ZengEn-Duo WangRu-Juan LiuPublished in: The EMBO journal (2021)
Since numerous RNAs and RBPs prevalently localize to active chromatin regions, many RNA-binding proteins (RBPs) may be potential transcriptional regulators. RBPs are generally thought to regulate transcription via noncoding RNAs. Here, we describe a distinct, dual mechanism of transcriptional regulation by the previously uncharacterized tRNA-modifying enzyme, hTrmt13. On one hand, hTrmt13 acts in the cytoplasm to catalyze 2'-O-methylation of tRNAs, thus regulating translation in a manner depending on its tRNA-modification activity. On the other hand, nucleus-localized hTrmt13 directly binds DNA as a transcriptional co-activator of key epithelial-mesenchymal transition factors, thereby promoting cell migration independent of tRNA-modification activity. These dual functions of hTrmt13 are mutually exclusive, as it can bind either DNA or tRNA through its CHHC zinc finger domain. Finally, we find that hTrmt13 expression is tightly associated with poor prognosis and survival in diverse cancer patients. Our discovery of the noncatalytic roles of an RNA-modifying enzyme provides a new perspective for understanding epitranscriptomic regulation.
Keyphrases
- poor prognosis
- transcription factor
- cell migration
- long non coding rna
- epithelial mesenchymal transition
- gene expression
- circulating tumor
- nucleic acid
- cell free
- endothelial cells
- single molecule
- genome wide
- small molecule
- dna methylation
- signaling pathway
- transforming growth factor
- dna damage
- heat shock
- risk assessment
- oxidative stress
- human health
- climate change
- circulating tumor cells
- binding protein